SCYNEXIS

SCYNEXIS Non-Current Assets

The Non-Current Assets of SCYNEXIS (SCYX) as of Sep 27, 2026 is -24.13 M USD. In the previous year, Non-Current Assets was -46.07 M USD — a change of -47.63% (higher).

Non-Current Assets

-24.13 MUSD

YoY

-47.63%

Last updated:

Non-Current Assets of SCYNEXIS is 2026 -24.13 M USD. Non-Current Assets of SCYNEXIS was 2025 -46.07 M USD. It decreases by -47.63% higher compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Non-Current Assets of SCYNEXIS is -24.13 M USD in 2026.

Non-Current Assets of SCYNEXIS changed from -46.07 M USD to -24.13 M USD, representing a -47.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Non-Current Assets SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Non-current assets are long-term resources not expected to be converted to cash within one year, including property, equipment, and long-term investments.

Non-Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Non-Current Assets's SCYNEXIS historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — SCYNEXIS

All Key Metrics — SCYNEXIS